title: What can be done for patients with NSCLC without druggable targets?
authors: Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France.
authors: Benjamin
authors: B
authors: Besse
authors: Fabrice
authors: F
authors: Andre
authors: Jean-Charles
authors: JC
authors: Soria
mesh_terms: D000077548:Anaplastic Lymphoma Kinase; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics; D015894:Genome, Human; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics; D058990:Molecular Targeted Therapy; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics
chemical_list: D000077548:Anaplastic Lymphoma Kinase; C512478:EGFR protein, human; D066246:ErbB Receptors; D020794:Receptor Protein-Tyrosine Kinases